Digital Health Acquisition Corp. (DHAC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Digital Health Acquisition Corp. (DHAC) trades at $12.11 with AI Score 49/100 (Grade C). Digital Health Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in 2021, without significant operations. Market cap: $43.64M, Sector: Financial services.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for DHAC: DHAC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DHAC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
DHAC: the 1 perspectives are evenly split.
How is this calculated? →Digital Health Acquisition Corp. (DHAC) Financial Services Profile
Digital Health Acquisition Corp. (DHAC) is a special purpose acquisition company (SPAC) focused on identifying and combining with businesses in the technology and healthcare sectors. Incorporated in 2021, it operates without significant ongoing operations, aiming to leverage its capital for a strategic merger, share exchange, or asset acquisition within these high-growth industries.
What Is the Investment Thesis for DHAC?
Digital Health Acquisition Corp. (DHAC) presents an investment thesis centered on its potential to execute a transformative business combination within the technology and healthcare sectors. As a SPAC, its value proposition is inherently linked to the successful identification and merger with a high-growth private company. The company's focus on technology and healthcare positions it within industries characterized by significant innovation and market expansion, offering potential for substantial post-merger value creation. With a market capitalization of $43.64M, DHAC represents a vehicle for investors to gain exposure to these sectors, contingent on a successful de-SPAC transaction. The current financial metrics, including a profit margin of -92.4% and gross margin of 46.3%, reflect its status as a non-operating shell company. Its low Beta of 0.24 suggests limited correlation with broader market movements prior to a business combination. The primary catalyst for value realization is the announcement and successful completion of a merger, which could unlock significant growth opportunities from the acquired entity's operations. Conversely, the inherent risks include the failure to identify a suitable target within the specified timeframe, potential dilution, and market sentiment towards SPACs.
Based on FMP financials and quantitative analysis
DHAC Key Highlights
- Market Capitalization: $0.04 billion, reflecting its status as a special purpose acquisition company.
- Profit Margin: -92.4%, indicative of a non-operating entity incurring administrative expenses without revenue.
- Gross Margin: 46.3%, which is unusual for a non-operating company and likely reflects specific accounting for its capital structure or minimal revenue from interest on trust assets, if any.
- Beta: 0.24, suggesting low volatility relative to the broader market, typical for a pre-merger SPAC.
- Dividend Yield: None, as the company does not pay dividends, consistent with its SPAC structure and lack of operational profits.
Who Are DHAC's Competitors?
DHAC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NSH NavSight Holdings, Inc. | $9.93 | +3.01% | 69 | |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.39M | 68 |
| LMAOU LMF Acquisition Opportunities, Inc. | $12.46 | +41.59% | 68 | |
| APXTW Apex Treasury Corporation | $0.37 | +5.11% | $1.96B | 66 |
| DGNR Dragoneer Growth Opportunities Corp. | $9.26 | +0.00% | $5.79B | 57 |
| KWM K Wave Media Ltd. | $0.15 | -2.40% | $10.04M | 57 |
| IOAC Innovative International Acquisition Corp. | $9.60 | -14.44% | $100.74M | 57 |
| ROCGU Roth CH Acquisition IV Co. | $10.29 | +2.90% | $57.15M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DHAC's Key Strengths?
- Focused mandate on high-growth technology and healthcare sectors.
- Access to public capital markets for potential target companies.
- Streamlined path for private companies to go public compared to traditional IPOs.
What Are DHAC's Weaknesses?
- No significant operations or revenue generation prior to a business combination.
- Reliance on identifying a suitable acquisition target within a limited timeframe.
- Profit margin of -92.4% reflects ongoing expenses without operational income.
What Could Drive DHAC Stock Higher?
- Announcement of a definitive agreement for a business combination with a target company in the technology or healthcare sector.
- Shareholder approval of a proposed de-SPAC transaction, leading to the merger or acquisition completion.
- Continued due diligence and negotiation efforts to identify and secure a high-quality private company for acquisition.
What Are the Key Risks for DHAC?
- Financial-distress signal — its Altman Z-Score of -4.32 sits in the distress zone (elevated bankruptcy risk).
- Failure to identify and complete a suitable business combination within the mandated timeframe, leading to the liquidation of the SPAC and return of funds to shareholders.
- Negative market sentiment or increased regulatory scrutiny towards SPACs, potentially impacting investor confidence and the valuation of the combined entity post-merger.
- Dilution of shareholder value if the terms of a future business combination involve significant issuance of new shares or warrants.
- Inability to secure sufficient shareholder approval for a proposed merger, leading to the termination of the transaction.
What Are the Growth Opportunities for DHAC?
- Digital Health Market Expansion: The digital health market is experiencing substantial growth, driven by advancements in telemedicine, remote patient monitoring, AI-powered diagnostics, and health data analytics. DHAC's explicit focus on healthcare-focused businesses positions it to capitalize on this expansion by acquiring a company poised for significant scale within this evolving landscape. A successful de-SPAC with an innovative digital health firm could provide investors exposure to a market projected to reach hundreds of billions of dollars globally in the coming years, offering long-term growth potential through technological adoption and improved healthcare outcomes.
- Healthcare Technology Innovation: Beyond digital health, the broader healthcare technology sector, encompassing biotech, medical devices, and health IT infrastructure, continues to attract significant investment due to ongoing innovation. DHAC's mandate to target technology and healthcare businesses allows it to pursue companies developing disruptive solutions that address critical industry needs. Acquiring a company with proprietary technology or a strong intellectual property portfolio in areas like gene sequencing, precision medicine, or advanced surgical robotics could unlock substantial value, driven by new product development and market penetration over the next 5-10 years.
- Strategic M&A in Technology Sector: The technology sector remains highly active for mergers and acquisitions, fueled by consolidation, the pursuit of synergistic capabilities, and the need for scale. DHAC's intention to focus on technology-focused businesses provides an opportunity to acquire a company that could benefit from public market access and further M&A activity. A successful business combination with a robust software, AI, or cybersecurity firm could position the combined entity for accelerated growth through expanded market reach, enhanced product offerings, and strategic partnerships, potentially leading to significant shareholder value creation within a 3-5 year horizon.
- Post-Combination Synergies and Operational Efficiency: A key growth driver for any SPAC transaction lies in the potential for post-combination synergies and operational efficiencies. Should DHAC successfully merge with a target company, the combined entity could realize cost savings through shared resources, optimized supply chains, and integrated back-office functions. Furthermore, the infusion of public market capital and the strategic guidance from DHAC's management team could enable the acquired business to accelerate its growth initiatives, invest in R&D, and expand into new markets more rapidly than it could as a private entity, driving sustained growth over the medium term.
- Access to Public Markets for Target Companies: For many private technology and healthcare companies, a SPAC merger offers a streamlined and potentially faster route to public markets compared to a traditional IPO. DHAC provides an attractive alternative for growth-stage companies seeking capital and liquidity. By facilitating this transition, DHAC positions itself as a crucial partner, potentially attracting high-quality targets that might otherwise remain private or face longer, more complex IPO processes. This access to public capital can fuel the target company's expansion, product development, and market penetration, contributing to the combined entity's growth trajectory over the long term.
What Opportunities Does DHAC Have?
- Successful merger with an innovative, high-growth private company in target sectors.
- Capitalization on strong market trends in digital health and technology.
- Potential for significant value creation post-merger through operational synergies and market expansion.
What Threats Does DHAC Face?
- Failure to complete a business combination within the required timeframe, leading to liquidation.
- Increased regulatory scrutiny and negative market sentiment towards SPACs.
- Intense competition from other SPACs, private equity, and venture capital for attractive targets.
- Economic downturns or sector-specific headwinds impacting target company valuations.
What Are DHAC's Competitive Advantages?
- Access to Capital: The capital raised through its initial public offering provides a ready source of funding for a target company's growth and public market entry.
- Public Market Access Vehicle: Offers private technology and healthcare companies a potentially faster and more streamlined route to becoming publicly traded compared to a traditional IPO.
- Targeted Sector Focus: Specialization in technology and healthcare allows for a focused search and potentially deeper understanding of specific market opportunities and challenges within these dynamic industries.
What Does DHAC Do?
Digital Health Acquisition Corp. (DHAC) operates as a special purpose acquisition company (SPAC), a unique entity designed to raise capital through an initial public offering (IPO) with the sole purpose of acquiring an existing private company. Incorporated in 2021 and headquartered in Boca Raton, Florida, DHAC explicitly states that it does not possess significant operations of its own. Its strategic mandate is to identify, evaluate, and ultimately execute a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar transaction with one or more businesses or entities. The company has articulated a clear focus on target businesses within the technology and healthcare sectors. This specialization reflects a strategic intent to capitalize on the innovation and growth potential inherent in these dynamic industries. By concentrating its efforts on these specific domains, DHAC aims to present an attractive proposition to potential target companies seeking to access public markets, while also offering investors exposure to these sectors through a de-SPAC transaction. The company's existence is predicated on the successful identification and integration of a suitable operating business, transforming it from a shell company into an active, publicly traded entity. Until such a combination is achieved, DHAC's activities are primarily centered around due diligence, target sourcing, and regulatory compliance related to its SPAC structure.
What Products and Services Does DHAC Offer?
- Operates as a Special Purpose Acquisition Company (SPAC).
- Does not have significant ongoing business operations.
- Focuses on identifying and acquiring one or more private businesses.
- Intends to effect a business combination through merger, share exchange, or asset acquisition.
- Specifically targets businesses within the technology sector.
- Also targets businesses within the healthcare sector.
- Aims to provide a private company with a path to becoming a publicly traded entity.
- Headquartered in Boca Raton, Florida, and incorporated in 2021.
How Does DHAC Make Money?
- Raises capital through an initial public offering (IPO) to form a trust.
- Uses the proceeds from the IPO to search for and acquire a private operating company.
- Aims to complete a "de-SPAC" transaction, merging with or acquiring the target company.
- The value creation for shareholders is contingent on the successful identification and integration of a high-growth target.
- Shareholders typically have the option to redeem their shares if they do not approve of the proposed business combination.
What Industry Does DHAC Operate In?
Digital Health Acquisition Corp. operates within the unique and often scrutinized landscape of the Special Purpose Acquisition Company (SPAC) industry, which falls under the broader Financial Services sector. SPACs serve as alternative vehicles for private companies to go public, bypassing traditional IPO processes. The industry has experienced cycles of significant investor interest and subsequent regulatory scrutiny. DHAC's specific focus on technology and healthcare places it within two of the most dynamic and capital-intensive sectors globally. The digital health market, for instance, is projected to continue its robust growth, driven by technological advancements, increasing healthcare demands, and digital transformation initiatives. Similarly, the broader technology sector remains a hotbed for innovation and M&A activity. DHAC's competitive landscape includes other SPACs targeting similar industries, as well as traditional venture capital firms and private equity funds that also seek to invest in and bring private companies to market. Its positioning is defined by its ability to identify and attract a high-quality target company within its specified focus areas, differentiating itself through management expertise and capital deployment strategy.
Who Are DHAC's Key Customers?
- Private operating companies in the technology sector seeking to go public.
- Private operating companies in the healthcare sector seeking to go public.
- Investors seeking exposure to high-growth private companies through a public vehicle.
DHAC Valuation & Market Position
With a $43.64M market cap, Digital Health Acquisition Corp. sits in the micro-cap segment of the market. Relative to its peer group, DHAC's quantitative score of 49/100 is below the peer average of 65/100.
Key Financial Metrics
Return on assets is -70.2%, showing how much profit it generates from its asset base. A current ratio of 0.41 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
Digital Health Acquisition Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -4.32 places it in the distress zone, a signal of elevated financial risk.
DHAC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that key stakeholders believe in its growth potential.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative approach in the digital health sector.
- Analysts have noted increasing interest from institutional investors, reflecting a belief in the long-term viability of digital health solutions.
- The ongoing trend towards telehealth and digital health solutions aligns well with the company's strategic vision, positioning it favorably in a growing market.
Bear Case
- Market perception remains cautious due to the overall volatility in SPACs, which can lead to uncertainty about future performance.
- Recent social sentiment has shown some skepticism regarding the company's ability to execute its business model effectively in a competitive landscape.
- Concerns over regulatory scrutiny in the healthcare sector could pose challenges for the company's operations and growth.
- Some community voices express doubts about the sustainability of recent hype around digital health, suggesting it may not translate into long-term success.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
DHAC Latest News
DHAC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DHAC.
Price Targets
Wall Street price target analysis for DHAC.
DHAC MoonshotScore
What does this score mean?
The MoonshotScore rates DHAC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Scott J. Wolf
Unknown
Unknown
Track Record: Unknown
Common Questions About DHAC (Financial Services)
What does Digital Health Acquisition Corp. do?
Digital Health Acquisition Corp. (DHAC) operates as a special purpose acquisition company, commonly known as a SPAC. Its core function is to raise capital through an initial public offering (IPO) and then use those funds to acquire or merge with an existing private company. Unlike traditional operating companies, DHAC does not have its own significant business operations or revenue-generating activities. Instead, its primary objective is to identify a suitable target business, specifically focusing on entities within the technology and healthcare sectors, and facilitate its transition to a publicly traded entity through a business combination such as a merger or asset acquisition. The company was incorporated in 2021 and is based in Boca Raton, Florida, dedicated solely to this acquisition mandate.
How does DHAC generate value for shareholders given its lack of operations?
Digital Health Acquisition Corp. generates potential value for shareholders through the successful execution of its business combination strategy. As a SPAC, its intrinsic value is tied to its ability to identify and merge with a high-growth private company, particularly within the technology and healthcare sectors. Upon a successful "de-SPAC" transaction, the combined entity becomes an operating company, and its value is then derived from the performance, growth prospects, and market position of the acquired business. Shareholders who invest in DHAC are essentially investing in the management team's ability to source and integrate a promising private company, providing them with public market exposure to a potentially high-growth sector that might otherwise be inaccessible. The pre-merger financial metrics, such as a -92.4% profit margin, reflect its non-operating status, with value creation contingent on future M&A success.
What are the primary risks associated with investing in a SPAC like DHAC?
Investing in Digital Health Acquisition Corp. carries several inherent risks specific to its SPAC structure. A primary concern is the "de-SPAC risk," which is the potential failure to identify and complete a suitable business combination within the company's mandated timeframe, typically 18-24 months. If no acquisition occurs, the SPAC liquidates, returning funds to shareholders, often at or near the initial IPO price, but without any capital appreciation. There's also the risk of potential dilution from warrants or additional share issuances during the merger process. Furthermore, market sentiment towards SPACs can be volatile, impacting the stock's performance even before a merger. The quality of the target company and the terms of the merger agreement are critical, as a poor acquisition choice could lead to underperformance post-combination.
How sensitive is DHAC to market sentiment regarding SPACs and de-SPAC transactions?
Digital Health Acquisition Corp.'s valuation and investor interest are highly sensitive to broader market sentiment concerning Special Purpose Acquisition Companies (SPACs) and the success rate of de-SPAC transactions. In periods of high enthusiasm for SPACs, investor capital flows readily into these vehicles, potentially boosting DHAC's trading price even before a target is identified. Conversely, during periods of increased regulatory scrutiny, concerns about post-merger performance, or general market downturns, investor confidence in the SPAC model can wane significantly. This can lead to redemptions by existing shareholders, making it harder for DHAC to complete a merger, or resulting in a lower valuation for the combined entity. The company's ability to attract a high-quality target and secure favorable merger terms is directly influenced by the prevailing market perception of the SPAC ecosystem.
What are the key factors to evaluate for DHAC?
Digital Health Acquisition Corp. (DHAC) holds an AI score of 49/100 (low). Not financial advice.
How frequently does DHAC data refresh on this page?
DHAC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven DHAC's recent stock price performance?
Digital Health Acquisition Corp. (DHAC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focused mandate on high-growth technology and healthcare sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DHAC overvalued or undervalued right now?
Valuing Digital Health Acquisition Corp. (DHAC) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited source data available for a non-operating SPAC, requiring focus on its stated intentions and industry context.
- CEO background and track record are 'Unknown' due to lack of specific data in the source.
- Competitors list is empty as no FMP PEER TICKERS were provided.